semaglutide discontinuation study denmark 2025 september Quarterly incidence rate of new users (A) and quarterly total user Titration and discontinuation of semaglutide

These researchers commented that the increases in cortical and total BMC were due to an increased growth of the bones with increased bone dimensions

Its about mechanism, evidence, and whether youre willing to do the work that makes either one effective

FDA still has to move through rulemaking, and DSIP deserves a fair second look with the right data in front of the Committee

They mimic the action of GLP-1, helping individuals feel full faster

The decision to switch should be guided by a healthcare professional , taking into account your health goals, previous response to treatment , and ability to tolerate medication changes

It also flags that, in a real-world environment, a meaningful share of patients may not tolerate the full dose